- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 89Zr-NY005
Total 116 results
-
Radboud University Medical CenterPfizer; ImaginAb, Inc.; University Hospital TuebingenNot yet recruitingNSCLCGermany, Netherlands
-
Memorial Sloan Kettering Cancer CenterRecruitingMelanoma | Melanoma Stage IIIUnited States
-
Brigham and Women's HospitalCompletedPulmonary Arterial Hypertension | Exercise Associated Pulmonary Arterial HypertensionUnited States
-
James BrugarolasRecruitingRenal Cell CarcinomaUnited States
-
University Medical Center GroningenAmsterdam UMC, location VUmc; University Medical Center NijmegenActive, not recruitingMetastatic Breast CancerNetherlands
-
National Jewish HealthNational Institute on Drug Abuse (NIDA)Active, not recruitingHypnotic Dependence Among Those With InsomniaUnited States
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkins LymphomaBelgium, Spain, Denmark, Italy, United Kingdom, Israel, United States
-
University Medical Center GroningenNovartis PharmaceuticalsCompletedNeuroendocrine TumorsNetherlands
-
Andrei IagaruNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSquamous Cell Carcinoma of the Head and Neck | Carcinoma of the Head and NeckUnited States
-
Radboud University Medical CenterAstraZenecaCompletedNon-small Cell Lung CancerNetherlands
-
Memorial Sloan Kettering Cancer CenterRecruitingKidney Cancer | Clear Cell Renal Cell Carcinoma | Advanced Renal Cell CarcinomaUnited States
-
Robert Flavell, MD, PhDNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Plasma Cell MyelomaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedInflammatory Breast CarcinomaUnited States
-
Zhujiang HospitalRecruitingProstate Cancer With ≤10 Bone MetastasesChina
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
Robert Flavell, MD, PhDUnited States Department of Defense; Fortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States